WEP Faculty - Stephen M. Sammut

The Goergen Entrepreneurial Management Program

Stephen Sammut Stephen M. Sammut
Venture Partner, Burrill & Company
Lecturer, Wharton
smsammut@wharton.upenn.edu

Courses:

Management 804: Venture Capital and Entrepreneurial Management
Management 809: Private Equity in Emerging Markets
Health Care Management 868: Role of Private Sector in Global Health

Bio:

Stephen M. Sammut has a career that is both commercial and academic. Outside of Wharton, Mr. Sammut is Venture Partner, Burrill & Company, a merchant bank and venture capital fund focused on the life sciences. His role there is general management of overseas venture capital funds, particularly in the Asia-Pacific region and the Middle East.

Academically, he currently holds an appointment as Lecturer, Wharton Entrepreneurial Programs and Senior Fellow, Wharton Health Care Management. During his 17 years at Wharton, Mr. Sammut has created or taught eight courses throughout the University.

In addition to his teaching in Wharton Entrepreneurial Programs, he leads a project with the Latin American Venture Capital Association on the study of venture capital and private equity activity and growth in the region.

Mr. Sammut's course on global health in the Health Care Management department is linked to research underway - in collaboration with the McLaughlin-Rotman Center for Global Health at the University of Toronto - that is studying the capacity of countries such as India, China, South Africa, and Brazil to develop indigenous pharmaceutical and biotechnology industries. The project is funded by the Bill & Melinda Gates Foundation.

During his private sector career, Mr. Sammut has been involved in the creation or funding of nearly 40 biotechnology, Internet, and information technology companies globally. He is on numerous Boards of Directors including Doctors of the World, the Center for Medicine in the Public Interest, Dynamis Therapeutics, Combinent BioMedical Systems, and serves as a senior advisor to Mitsubishi Corporation’s Life Science Business Unit, the Royal Bank of Canada Strategic Technology Fund, the Cornell Research Foundation, Sandhurst Capital (an African PE and venture capital fund) and the Asia-Pacific Fund. He is also a member of the publications board of the European Venture Capital Association, the Journal of Commercial Biotechnology, and the Journal of BioLaw and BioBusiness.

He holds graduate and undergraduate degrees from Villanova University in biological sciences and philosophy, attended Hahnemann Medical College for two years, and holds an MBA from the Wharton School.



	LOGIN HOME NEWS & EVENTS ENTREPRENEURIAL CAREERS STARTING A BUSINESS TEACHING & LEARNING Overview Undergraduate Program MBA Program Doctoral Program MBA for Executives Faculty Wharton Management Department Admissions RESEARCH ALUMNI		The Goergen Entrepreneurial Management Program Stephen M. Sammut Venture Partner, Burrill & Company Lecturer, Wharton smsammut@wharton.upenn.edu Courses: Management 804: Venture Capital and Entrepreneurial Management Management 809: Private Equity in Emerging Markets Health Care Management 868: Role of Private Sector in Global Health Bio: Stephen M. Sammut has a career that is both commercial and academic. Outside of Wharton, Mr. Sammut is Venture Partner, Burrill & Company, a merchant bank and venture capital fund focused on the life sciences. His role there is general management of overseas venture capital funds, particularly in the Asia-Pacific region and the Middle East. Academically, he currently holds an appointment as Lecturer, Wharton Entrepreneurial Programs and Senior Fellow, Wharton Health Care Management. During his 17 years at Wharton, Mr. Sammut has created or taught eight courses throughout the University. In addition to his teaching in Wharton Entrepreneurial Programs, he leads a project with the Latin American Venture Capital Association on the study of venture capital and private equity activity and growth in the region. Mr. Sammut's course on global health in the Health Care Management department is linked to research underway - in collaboration with the McLaughlin-Rotman Center for Global Health at the University of Toronto - that is studying the capacity of countries such as India, China, South Africa, and Brazil to develop indigenous pharmaceutical and biotechnology industries. The project is funded by the Bill & Melinda Gates Foundation. During his private sector career, Mr. Sammut has been involved in the creation or funding of nearly 40 biotechnology, Internet, and information technology companies globally. He is on numerous Boards of Directors including Doctors of the World, the Center for Medicine in the Public Interest, Dynamis Therapeutics, Combinent BioMedical Systems, and serves as a senior advisor to Mitsubishi Corporation’s Life Science Business Unit, the Royal Bank of Canada Strategic Technology Fund, the Cornell Research Foundation, Sandhurst Capital (an African PE and venture capital fund) and the Asia-Pacific Fund. He is also a member of the publications board of the European Venture Capital Association, the Journal of Commercial Biotechnology, and the Journal of BioLaw and BioBusiness. He holds graduate and undergraduate degrees from Villanova University in biological sciences and philosophy, attended Hahnemann Medical College for two years, and holds an MBA from the Wharton School.